View by Specialty

Trending

IDC1024Hoberman_graphic
November 04, 2024
4 min read
Save

Q&A: App ‘much better’ than physicians at diagnosing ear infections

Steatohepatitis/Metabolic Liver Disease News

SPONSORED CONTENT
Save
SPONSORED CONTENT
January 18, 2024
2 min read
Save

Glucose-lowering therapies linked to reduced risk for CV events in type 2 diabetes, MASLD

Glucose-lowering therapies linked to reduced risk for CV events in type 2 diabetes, MASLD

Sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists were associated with lower risk for cardiovascular events in type 2 diabetes, with or without metabolic dysfunction-associated steatotic liver disease.

SPONSORED CONTENT
January 12, 2024
5 min read
Save

Dry January campaign aims to make ‘first step’ toward abstinence less daunting

Dry January campaign aims to make ‘first step’ toward abstinence less daunting

Each January, Alcohol Change UK runs Dry January, a post-holiday campaign that encourages people to abstain from alcohol for 31 days at the beginning of the year and drink more healthily year-round.

Trending

IDC1024Hoberman_graphic
November 04, 2024
4 min read
Save

Q&A: App ‘much better’ than physicians at diagnosing ear infections

SPONSORED CONTENT
January 09, 2024
4 min watch
Save

VIDEO: Investigational FGF-21 improves liver fat, glycemic control markers in MASH, diabetes

VIDEO: Investigational FGF-21 improves liver fat, glycemic control markers in MASH, diabetes

BOSTON — In this video, Rohit Loomba, MD, MHSc, discusses data supporting once-monthly dosing of BOS-580, an investigational, long-acting fibroblast growth factor-21 analog for treatment of metabolic dysfunction-associated steatohepatitis.

SPONSORED CONTENT
January 04, 2024
2 min read
Save

ACG publishes new guideline for management of alcohol-associated liver disease

ACG publishes new guideline for management of alcohol-associated liver disease

A new clinical guideline published in the American Journal of Gastroenterology underscored the need to overcome barriers to alcohol use disorder treatment and expand multidisciplinary care for patients with alcohol-associated liver disease.

SPONSORED CONTENT
December 18, 2023
2 min watch
Save

VIDEO: NAFLD upgrade to MASLD offers ‘less stigmatizing’ positive diagnosis for patients

VIDEO: NAFLD upgrade to MASLD offers ‘less stigmatizing’ positive diagnosis for patients

In a Healio video exclusive, Edward V. Loftus Jr., MD, highlighted how rebranding nonalcoholic fatty liver disease as metabolic dysfunction-associated steatotic liver disease offers a “positive diagnosis” without the associated stigma.

SPONSORED CONTENT
December 18, 2023
2 min read
Save

Nomenclature change brings new opportunities for research, drug development

Nomenclature change brings new opportunities for research, drug development

The renaming of nonalcoholic steatohepatitis and nonalcoholic fatty liver disease to metabolic dysfunction-associated steatohepatitis and metabolic dysfunction-associated steatotic liver disease is a long time coming.

SPONSORED CONTENT
December 18, 2023
10 min read
Save

No patient left behind: MASLD rebranding provides ‘affirmative diagnosis’ without stigma

No patient left behind: MASLD rebranding provides ‘affirmative diagnosis’ without stigma

In June 2023, 74% of respondents from a multinational, multisociety Delphi process agreed that the term nonalcoholic fatty liver disease was “sufficiently flawed” and 89% preferred nomenclature that described the underlying cause of disease.

SPONSORED CONTENT
December 14, 2023
2 min read
Save

Researchers advise limit of 7.4 grams of alcohol per day in early steatotic liver disease

Researchers advise limit of 7.4 grams of alcohol per day in early steatotic liver disease

Researchers recommended that patients with steatotic liver disease who are at a lower risk for advanced cirrhosis should consume no more than 7.4 grams of alcohol per day, the equivalent of a half a 12 oz. beer or half a glass of wine.

SPONSORED CONTENT
December 08, 2023
2 min read
Save

More education needed to help PCPs ‘feel confident’ treating, managing MASLD

More education needed to help PCPs ‘feel confident’ treating, managing MASLD

BOSTON — Although primary care physicians play a vital role in managing metabolic dysfunction-associated steatotic liver disease, many are not following guidance on screening, risk stratification or referrals, according to research.

SPONSORED CONTENT
December 07, 2023
2 min read
Save

Women with food insecurity, low BMI more likely to have hepatic steatosis

Women with food insecurity, low BMI more likely to have hepatic steatosis

BOSTON — Women who experience food insecurity and have a BMI less than 25 kg/m2 had higher odds of hepatic steatosis compared with overweight women or those with obesity, regardless of HIV status, according to research at The Liver Meeting.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails